PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WUXAY vs. TEVA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between WUXAY and TEVA is 0.03, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.0

Performance

WUXAY vs. TEVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WuXi AppTec Co. Ltd (WUXAY) and Teva Pharmaceutical Industries Limited (TEVA). The values are adjusted to include any dividend payments, if applicable.

0.00%20.00%40.00%60.00%80.00%100.00%SeptemberOctoberNovemberDecember2025February
66.19%
1.61%
WUXAY
TEVA

Key characteristics

Sharpe Ratio

WUXAY:

0.11

TEVA:

0.84

Sortino Ratio

WUXAY:

0.76

TEVA:

1.72

Omega Ratio

WUXAY:

1.10

TEVA:

1.22

Calmar Ratio

WUXAY:

0.11

TEVA:

0.45

Martin Ratio

WUXAY:

0.32

TEVA:

5.97

Ulcer Index

WUXAY:

29.33%

TEVA:

6.18%

Daily Std Dev

WUXAY:

78.49%

TEVA:

44.15%

Max Drawdown

WUXAY:

-83.96%

TEVA:

-90.80%

Current Drawdown

WUXAY:

-65.92%

TEVA:

-74.53%

Fundamentals

Market Cap

WUXAY:

$21.25B

TEVA:

$19.33B

EPS

WUXAY:

$0.40

TEVA:

-$1.43

Total Revenue (TTM)

WUXAY:

$27.56B

TEVA:

$16.56B

Gross Profit (TTM)

WUXAY:

$11.04B

TEVA:

$8.07B

EBITDA (TTM)

WUXAY:

$8.45B

TEVA:

$480.00M

Returns By Period

In the year-to-date period, WUXAY achieves a 3.86% return, which is significantly higher than TEVA's -22.60% return.


WUXAY

YTD

3.86%

1M

9.25%

6M

64.35%

1Y

35.38%

5Y*

N/A

10Y*

N/A

TEVA

YTD

-22.60%

1M

-19.68%

6M

0.89%

1Y

37.80%

5Y*

7.11%

10Y*

-10.74%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

WUXAY vs. TEVA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WUXAY
The Risk-Adjusted Performance Rank of WUXAY is 5252
Overall Rank
The Sharpe Ratio Rank of WUXAY is 5151
Sharpe Ratio Rank
The Sortino Ratio Rank of WUXAY is 5353
Sortino Ratio Rank
The Omega Ratio Rank of WUXAY is 5353
Omega Ratio Rank
The Calmar Ratio Rank of WUXAY is 5252
Calmar Ratio Rank
The Martin Ratio Rank of WUXAY is 5151
Martin Ratio Rank

TEVA
The Risk-Adjusted Performance Rank of TEVA is 7575
Overall Rank
The Sharpe Ratio Rank of TEVA is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of TEVA is 7676
Sortino Ratio Rank
The Omega Ratio Rank of TEVA is 7474
Omega Ratio Rank
The Calmar Ratio Rank of TEVA is 6666
Calmar Ratio Rank
The Martin Ratio Rank of TEVA is 8484
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

WUXAY vs. TEVA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for WuXi AppTec Co. Ltd (WUXAY) and Teva Pharmaceutical Industries Limited (TEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for WUXAY, currently valued at 0.11, compared to the broader market-2.000.002.004.000.110.84
The chart of Sortino ratio for WUXAY, currently valued at 0.76, compared to the broader market-4.00-2.000.002.004.000.761.72
The chart of Omega ratio for WUXAY, currently valued at 1.10, compared to the broader market0.501.001.502.001.101.22
The chart of Calmar ratio for WUXAY, currently valued at 0.11, compared to the broader market0.002.004.006.000.111.47
The chart of Martin ratio for WUXAY, currently valued at 0.32, compared to the broader market-10.000.0010.0020.0030.000.325.97
WUXAY
TEVA

The current WUXAY Sharpe Ratio is 0.11, which is lower than the TEVA Sharpe Ratio of 0.84. The chart below compares the historical Sharpe Ratios of WUXAY and TEVA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
0.11
0.84
WUXAY
TEVA

Dividends

WUXAY vs. TEVA - Dividend Comparison

WUXAY's dividend yield for the trailing twelve months is around 1.86%, while TEVA has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
WUXAY
WuXi AppTec Co. Ltd
1.86%1.93%1.24%0.76%0.26%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TEVA
Teva Pharmaceutical Industries Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%4.49%3.75%2.07%2.38%

Drawdowns

WUXAY vs. TEVA - Drawdown Comparison

The maximum WUXAY drawdown since its inception was -83.96%, smaller than the maximum TEVA drawdown of -90.80%. Use the drawdown chart below to compare losses from any high point for WUXAY and TEVA. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-65.92%
-25.08%
WUXAY
TEVA

Volatility

WUXAY vs. TEVA - Volatility Comparison

WuXi AppTec Co. Ltd (WUXAY) has a higher volatility of 19.12% compared to Teva Pharmaceutical Industries Limited (TEVA) at 17.02%. This indicates that WUXAY's price experiences larger fluctuations and is considered to be riskier than TEVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%35.00%40.00%SeptemberOctoberNovemberDecember2025February
19.12%
17.02%
WUXAY
TEVA

Financials

WUXAY vs. TEVA - Financials Comparison

This section allows you to compare key financial metrics between WuXi AppTec Co. Ltd and Teva Pharmaceutical Industries Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab